Literature DB >> 15113887

Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins.

Eric A Hehl1, Pheroze Joshi, Ganjam V Kalpana, Vinayaka R Prasad.   

Abstract

Reverse transcriptase (RT) and integrase (IN) are two key catalytic enzymes encoded by all retroviruses. It has been shown that a specific interaction occurs between the human immunodeficiency virus type 1 (HIV-1) RT and IN proteins (X. Wu, H. Liu, H. Xiao, J. A. Conway, E. Hehl, G. V. Kalpana, V. R. Prasad, and J. C. Kappes, J. Virol. 73:2126-2135, 1999). We have now further examined this interaction to map the binding domains and to determine the effects of interaction on enzyme function. Using recombinant purified proteins, we have found that both a HIV-1 RT heterodimer (p66/p51) and its individual subunits, p51 and p66, are able to bind to HIV-1 IN. An oligomerization-defective mutant of IN, V260E, retained the ability to bind to RT, showing that IN oligomerization may not be required for interaction. Furthermore, we report that the C-terminal domain of IN, but not the N-terminal zinc-binding domain or the catalytic core domain, was able to bind to heterodimeric RT. Deletion analysis to map the IN-binding domain on RT revealed two separate IN-interacting domains: the fingers-palm domain and the carboxy-terminal half of the connection subdomain. The carboxy-terminal domain of IN alone retained its interaction with both the fingers-palm and the connection-RNase H fragments of RT, but not with the half connection-RNase H fragment. This interaction was not bridged by nucleic acids, as shown by micrococcal nuclease treatment of the proteins prior to the binding reaction. The influences of IN and RT on each other's activities were investigated by performing RT processivity and IN-mediated 3' processing and joining reactions in the presence of both proteins. Our results suggest that, while IN had no influence on RT processivity, RT stimulated the IN-mediated strand transfer reaction in a dose-dependent manner up to 155-fold. Thus, a functional interaction between these two viral enzymes may occur during viral replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113887      PMCID: PMC400328          DOI: 10.1128/jvi.78.10.5056-5067.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains).

Authors:  T Unge; S Knight; R Bhikhabhai; S Lövgren; Z Dauter; K Wilson; B Strandberg
Journal:  Structure       Date:  1994-10-15       Impact factor: 5.006

3.  Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding.

Authors:  R A Lutzke; R H Plasterk
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase.

Authors:  M D Andrake; A M Skalka
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

5.  Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.

Authors:  A S Reicin; G Kalpana; S Paik; S Marmon; S Goff
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Folding of the multidomain human immunodeficiency virus type-I integrase.

Authors:  D P Grandgenett; G Goodarzi
Journal:  Protein Sci       Date:  1994-06       Impact factor: 6.725

7.  Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.

Authors:  G V Kalpana; S Marmon; W Wang; G R Crabtree; S P Goff
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

8.  An essential interaction between distinct domains of HIV-1 integrase mediates assembly of the active multimer.

Authors:  V Ellison; J Gerton; K A Vincent; P O Brown
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

9.  Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.

Authors:  A D Leavitt; G Robles; N Alesandro; H E Varmus
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.

Authors:  X Ji; G J Klarmann; B D Preston
Journal:  Biochemistry       Date:  1996-01-09       Impact factor: 3.162

View more
  64 in total

1.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

2.  Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication.

Authors:  Zhujun Ao; Kallesh Danappa Jayappa; Binchen Wang; Yingfeng Zheng; Sam Kung; Eric Rassart; Reinhard Depping; Matthias Kohler; Eric A Cohen; Xiaojian Yao
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

3.  The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.

Authors:  Xiaoxia Wang; Zhujun Ao; Liyu Chen; Gary Kobinger; Jinyu Peng; Xiaojian Yao
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  A new functional role of HIV-1 integrase during uncoating of the viral core.

Authors:  Marisa S Briones; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Authors:  Jennifer Puglia; Tan Wang; Christine Smith-Snyder; Marie Cote; Michael Scher; Joelle N Pelletier; Sinu John; Colleen B Jonsson; Monica J Roth
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

8.  The self primer of the long terminal repeat retrotransposon Tf1 is not removed during reverse transcription.

Authors:  Angela Atwood-Moore; Kenneth Yan; Robert L Judson; Henry L Levin
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.

Authors:  Charles W Dobard; Marisa S Briones; Samson A Chow
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 10.  Retroviral Integrase: Then and Now.

Authors:  Mark D Andrake; Anna Marie Skalka
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.